Vivos Therapeutics (VVOS)

• Market cap: $18.6M
• 1 day: -3.36%
• 5 days: -14.59%
• 1 month: -25.65%
• 3 months: -31.45%
• 6 months: 7.12%
• Year to date: -25.65%
• 1 year: -29.93%
• 5 years: -98.59%
• 10 years: -98.59%
• Sector: Healthcare
• Industry: Surgical & Medical Instruments & Apparatus

About: Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

Employees: 114

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

300% more repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 1

218% more capital invested

Capital invested by funds: $631K [Q3] → $2.01M (+$1.37M) [Q4]

4.52% more ownership

Funds ownership: 5.14% [Q3] → 9.66% (+4.52%) [Q4]

13% less funds holding

Funds holding: 23 [Q3] → 20 (-3) [Q4]

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5